SCHEMBL6231910

SCHEMBL6231910

O=C1c2[nH]c3cc(Cl)ccc3c(=O)c2C(=O)N1Nc1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 4/20 0.44
CLK4 Q9HAZ1 3/20 0.44
AXL P30530 1/20 0.44
PTK2B Q14289 1/20 0.44
MAPKAPK5 Q8IW41 1/20 0.44
SRPK1 Q96SB4 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
ERBB2 P04626 1/20 0.40
FLT3 P36888 1/20 0.40
CSNK1G1 Q9HCP0 1/20 0.40
PARP1 P09874 1/20 0.39
CA9 Q16790 2/20 0.39
CA12 O43570 1/20 0.39
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CCNE2 O96020 1/20 0.38
CDK4 P11802 1/20 0.38
CCND1 P24385 1/20 0.38
CCNE1 P24864 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6231904 0.95 CA1 (0.41) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6231125 0.94 PIM1 (0.47) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6232252 0.93 LMNA (0.42) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6239738 0.93 CA1 (0.50) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6233755 0.91 PIM1 (0.40) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6233199 0.90 CYP19A1 (0.42) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6233754 0.83 MAPK13 (0.40) CA1CA2CA9LMNAMEN1
SCHEMBL6232338 0.81 CA1 (0.44) PIM1CLK4AXLPTK2BMAPKAPK5
SCHEMBL6231824 0.79 TUBB4A (0.42) PIM1CLK4CA1CA2CA9
SCHEMBL6236235 0.79 KDM4E (0.39) PIM1CLK4AXLPTK2BMAPKAPK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004582-B1 Pyridazino quinoline compounds ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
EP-0790996-B1 PYRIDAZINOQUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2002-03-27 EP disclosed
US-6232313-B1 TREATING STROKE OR EPILEPTIC CONVULSIONS ASSOCIATED WITH EXCESSIVE CALCIUM INFLUX IN THE BRAIN CAUSED BY EXCITATORY AMINO ACIDS ZENECA LIMITED (GB) 2001-05-15 US disclosed
US-6214826-B1 NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 2001-04-10 US disclosed
EP-0724583-B1 PYRIDAZINO QUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2000-12-13 EP disclosed
EP-1004582-A2 Pyridazino quinoline compounds AstraZeneca UK Limited (GB) 2000-05-31 EP disclosed
US-5744471-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1998-04-28 US disclosed
EP-0790996-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1997-08-27 EP disclosed
EP-0724583-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-08-07 EP disclosed
WO-1996015127-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-05-23 WO disclosed
WO-1995011244-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1995-04-27 WO disclosed